Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

Multiple squamous cell carcinomas arising in linear porokeratosis Multiple Plattenepithelkarzinome auf einer linearen Porokeratose (2025) Busch D, Berking C, Schliep S, Erfurt-Berge C Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp. (2025) Reinhold U, Philipp-Dormston WG, Dirschka T, Ostendorf R, Aschoff R, Berking C, Jäger A, et al. Journal article Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status (2025) Placke JM, Rajcsanyi LS, Herbst R, Terheyden P, Utikal J, Pföhler C, Kreuter A, et al. Journal article Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. (2025) Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, et al. Journal article Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases. (2025) Yalcin-Mutlu M, Kleyer A, Krönke G, Fagni F, Temiz SA, Meder C, Dietrich P, et al. Journal article A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article